BRANDON MOORE: Open Payments
NPI 1083902977 · PORT HURON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$538 in 25 payments from 9 companies in 2025. Trend: 2023 $321 · 2024 $276 · 2025 $538
Food & beverage: $454Education: $84
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 9 | $143 |
| Neurocrine BioSciences, Inc. | 5 | $99 |
| Teva Pharmaceuticals USA, Inc. | 1 | $84 |
| Axsome Therapeutics, Inc. | 3 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Alkermes, Inc. | 2 | $41 |
| Vanda Pharmaceuticals Inc. | 1 | $30 |
| Lundbeck LLC | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: COBENFY, INGREZZA, Auvelity, HETLIOZ, ABILIFY ASIMTUFII, REXULTI, LYBALVI, CAPLYTA.
Industry payments across MI — which companies pay providers there.
